TNDM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TNDM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-26), Tandem Diabetes Care's current share price is $51.73. Tandem Diabetes Care's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $17.99. Tandem Diabetes Care's Cyclically Adjusted PS Ratio for today is 2.88.
The historical rank and industry rank for Tandem Diabetes Care's Cyclically Adjusted PS Ratio or its related term are showing as below:
During the past years, Tandem Diabetes Care's highest Cyclically Adjusted PS Ratio was 8.81. The lowest was 0.79. And the median was 2.25.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Tandem Diabetes Care's adjusted revenue per share data for the three months ended in Mar. 2024 was $2.934. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $17.99 for the trailing ten years ended in Mar. 2024.
The historical data trend for Tandem Diabetes Care's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tandem Diabetes Care Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted PS Ratio | Get a 7-Day Free Trial | 2.22 | 1.35 | 1.14 | 1.66 | 1.97 |
For the Medical Devices subindustry, Tandem Diabetes Care's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Tandem Diabetes Care's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Tandem Diabetes Care's Cyclically Adjusted PS Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
Tandem Diabetes Care's Cyclically Adjusted PS Ratio for today is calculated as
Cyclically Adjusted PS Ratio | = | Share Price | / | Cyclically Adjusted Revenue per Share |
= | 51.73 | / | 17.99 | |
= | 2.88 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tandem Diabetes Care's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, Tandem Diabetes Care's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:
Adj_RevenuePerShare | = | Revenue per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 2.934 | / | 131.7762 | * | 131.7762 | |
= | 2.934 |
Current CPI (Mar. 2024) = 131.7762.
Tandem Diabetes Care Quarterly Data
Revenue per Share | CPI | Adj_RevenuePerShare | |
201406 | 4.439 | 100.560 | 5.817 |
201409 | 5.758 | 100.428 | 7.555 |
201412 | 7.586 | 99.070 | 10.090 |
201503 | 4.823 | 99.621 | 6.380 |
201506 | 5.253 | 100.684 | 6.875 |
201509 | 5.232 | 100.392 | 6.868 |
201512 | 9.652 | 99.792 | 12.745 |
201603 | 6.622 | 100.470 | 8.685 |
201606 | 7.539 | 101.688 | 9.770 |
201609 | 4.013 | 101.861 | 5.192 |
201612 | 9.366 | 101.863 | 12.116 |
201703 | 5.951 | 102.862 | 7.624 |
201706 | 4.262 | 103.349 | 5.434 |
201709 | 5.203 | 104.136 | 6.584 |
201712 | 3.982 | 104.011 | 5.045 |
201803 | 1.516 | 105.290 | 1.897 |
201806 | 0.670 | 106.317 | 0.830 |
201809 | 0.832 | 106.507 | 1.029 |
201812 | 1.324 | 105.998 | 1.646 |
201903 | 1.142 | 107.251 | 1.403 |
201906 | 1.602 | 108.070 | 1.953 |
201909 | 1.599 | 108.329 | 1.945 |
201912 | 1.830 | 108.420 | 2.224 |
202003 | 1.639 | 108.902 | 1.983 |
202006 | 1.808 | 108.767 | 2.190 |
202009 | 2.009 | 109.815 | 2.411 |
202012 | 2.700 | 109.897 | 3.238 |
202103 | 2.258 | 111.754 | 2.663 |
202106 | 2.622 | 114.631 | 3.014 |
202109 | 2.773 | 115.734 | 3.157 |
202112 | 3.241 | 117.630 | 3.631 |
202203 | 2.754 | 121.301 | 2.992 |
202206 | 3.125 | 125.017 | 3.294 |
202209 | 3.184 | 125.227 | 3.351 |
202212 | 3.425 | 125.222 | 3.604 |
202303 | 2.624 | 127.348 | 2.715 |
202306 | 3.022 | 128.729 | 3.094 |
202309 | 2.851 | 129.860 | 2.893 |
202312 | 3.010 | 129.419 | 3.065 |
202403 | 2.934 | 131.776 | 2.934 |
Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Thank you for viewing the detailed overview of Tandem Diabetes Care's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Dick Allen | director | 11045 ROSELLE STREET, SAN DIEGO CA 92121 |
Shannon Marie Hansen | officer: SVP & General Counsel | C/O TANDEM DIABETES CARE, INC., 11075 ROSELLE STREET, SAN DIEGO CA 92121 |
Leigh Vosseller | officer: Senior Vice President and CFO | C/O TANDEM DIABETES CARE, INC., 11075 ROSELLE STREET, SAN DIEGO CA 92121 |
Kathleen Mcgroddy-goetz | director | C/O TANDEM DIABETES CARE, INC., 11075 ROSELLE STREET, SAN DIEGO CA 92121 |
Peyton R Howell | director | C/O TANDEM DIABETES CARE, INC., 11075 ROSELLE STREET, SAN DIEGO CA 92121 |
David B Berger | officer: GENERAL COUNSEL | 11045 ROSELLE STREET, SAN DIEGO CA 92121 |
Malagueira Joao Paulo Falcao | director | C/O TANDEM DIABETES CARE, INC., 11075 ROSELLE STREET, SAN DIEGO CA 92121 |
Myoungil Cha | director | C/O TANDEM DIABETES CARE, INC., 11075 ROSELLE STREET, SAN DIEGO CA 92121 |
Kim D Blickenstaff | director, officer: PRESIDENT AND CEO | C/O MEDIVATION, INC., 201 SPEAR STREET, 3RD FLOOR, SAN FRANCISCO CA 94105 |
John F Sheridan | officer: EXECUTIVE VP AND COO | C/O TANDEM DIABETES CARE, INC., 11045 ROSELLE STREET, SAN DIEGO CA 92121 |
Christopher J Twomey | director | 4767 NEXUS CENTRE DRIVE, SAN DIEGO CA 92121 |
Rebecca B Robertson | director | ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO CA 94104 |
James Leal | officer: SVP, Operations | C/O TANDEM DIABETES CARE, INC., 11075 ROSELLE STREET, SAN DIEGO CA 92121 |
Elizabeth Anne Gasser | officer: EVP, Chief Strategy Officer | C/O TANDEM DIABETES CARE, INC., 11075 ROSELLE STREET, SAN DIEGO CA 92121 |
Susan Morrison | officer: CAO | 11045 ROSELLE STREET, SAN DIEGO CA 92121 |
From GuruFocus
By PRNewswire • 11-03-2023
By Business Wire • 01-22-2024
By Business Wire • 12-12-2023
By GuruFocus Research • 11-14-2023
By Business Wire • 12-06-2023
By Business Wire • 10-21-2023
By Business Wire • 11-01-2023
By Marketwired • 10-24-2023
By GuruFocus Research • 12-18-2023